Sinopharm Group Co (Sinopharm Group Co) EBIT per Share : $0.53 (TTM As of Sep. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co EBIT per Share?

Sinopharm Group Co's EBIT per Share for the three months ended in Sep. 2023 was $0.20. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.53.

During the past 3 years, the average EBIT per Share Growth Rate was 6.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 11.10% per year. During the past 10 years, the average EBIT per Share Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Sinopharm Group Co's EBIT per Share or its related term are showing as below:

SHTDF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 6.2 Med: 18.2 Max: 59.6
Current: 6.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sinopharm Group Co was 59.60% per year. The lowest was 6.20% per year. And the median was 18.20% per year.

SHTDF's 3-Year EBIT Growth Rate is ranked worse than
51.85% of 81 companies
in the Medical Distribution industry
Industry Median: 6.9 vs SHTDF: 6.20

Sinopharm Group Co's EBIT for the three months ended in Sep. 2023 was $620 Mil.

Sinopharm Group Co EBIT per Share Historical Data

The historical data trend for Sinopharm Group Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co EBIT per Share Chart

Sinopharm Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.83

0.94

1.05

1.02

1.01

Sinopharm Group Co Quarterly Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.23	0.33	-	0.20	-

Sinopharm Group Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Sinopharm Group Co's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	3167.684	/	3120.656
=	1.02

Sinopharm Group Co's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	620.406	/	3097.420
=	0.20

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.53

Sinopharm Group Co (OTCPK:SHTDF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Sinopharm Group Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co (Sinopharm Group Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (OTCPK:SHTDF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

SHTDY:USA 01099:Hong Kong X2S:Germany

Address

No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023

Website

http://www.sinopharmgroup.com.cn

Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.

Sinopharm Group Co (Sinopharm Group Co) Headlines

From GuruFocus

Matthews China Fund Comments on Sinopharm Group

By Vera Yuan Vera Yuan • 10-20-2014

Matthews China Fund Q3 2014 Commentary

By Holly LaFon Holly LaFon • 10-18-2014

Arnold Van Den Berg Buys Prem Watsa's Fairfax India, 3 Other Stocks in 3rd Quarter

By Holly LaFon Holly LaFon • 10-31-2017

Matthews China Fund Comments on Sinopharm

By Holly LaFon Holly LaFon • 05-19-2016

Matthews China Fund Comments on Sinopharm

By Sydnee Gatewood Sydnee Gatewood • 01-25-2021

Matthews China Fund 1st Quarter Commentary

By Holly LaFon Holly LaFon • 05-19-2016

Matthews China Fund Comments on Sinopharm

By Sydnee Gatewood Sydnee Gatewood • 07-30-2020